Few investigational therapies generate the kind of sustained industry attention that this particular BTK inhibitor has commanded over recent years. A growing body of clinical evidence, combined with a rapidly shifting treatment landscape across multiple autoimmune and inflammatory conditions, has created fertile ground for what could become one of the more significant pharmaceutical launches of ..